Helius Medical Technologies Inc HSDT.OQ HSDT.O is expected to show a rise in quarterly revenue when it reports results on November 7 (estimated) for the period ending September 30 2024
The Newtown Pennsylvania-based company is expected to report a 4.9% increase in revenue to $150 thousand from $143 thousand a year ago, according to the estimate from one analyst, based on LSEG data.
LSEG's mean analyst estimate for Helius Medical Technologies Inc is for a loss of $1.06 per share.
The one available analyst rating on the shares is "hold".
The mean earnings estimate of analysts was unchanged in the last three months.
This summary was machine generated November 6 at 14:00 GMT. All figures in US dollars unless otherwise stated. (For questions concerning the data in this report, contact Estimates.Support@lseg.com. For any other questions or feedback, contact RefinitivNewsSupport@thomsonreuters.com)
Comments